Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Linked sensitization by memory CD4+ T cells prevents costimulation blockade–induced transplantation tolerance
Michael S. Andrade, James S. Young, Jared M. Pollard, Dengping Yin, Maria-Luisa Alegre, Anita S. Chong
Michael S. Andrade, James S. Young, Jared M. Pollard, Dengping Yin, Maria-Luisa Alegre, Anita S. Chong
View: Text | PDF
Research Article Immunology Transplantation

Linked sensitization by memory CD4+ T cells prevents costimulation blockade–induced transplantation tolerance

  • Text
  • PDF
Abstract

Dominant infectious tolerance explains how brief tolerance-inducing therapies result in lifelong tolerance to donor antigens and “linked” third-party antigens, while recipient sensitization and ensuing immunological memory prevent the successful induction of transplant tolerance. In this study, we juxtapose these 2 concepts to test whether mechanisms of dominant infectious tolerance can control a limited repertoire of memory T and B cells. We show that sensitization to a single donor antigen is sufficient to prevent stable transplant tolerance, rendering it unstable. Mechanistic studies revealed that recall antibody responses and memory CD8+ T cell expansion were initially controlled, but memory CD4+Foxp3– T cell (Tconv) responses were not. Remarkably, naive donor-specific Tconvs at tolerance induction also acquired a resistance to tolerance, proliferating and acquiring a phenotype similar to memory Tconvs. This phenomenon of “linked sensitization” underscores the challenges of reprogramming a primed immune response toward tolerance and identifies a potential therapeutic checkpoint for synergizing with costimulation blockade to achieve transplant tolerance in the clinic.

Authors

Michael S. Andrade, James S. Young, Jared M. Pollard, Dengping Yin, Maria-Luisa Alegre, Anita S. Chong

×

Figure 5

Presensitization to donor Cre antigen results in linked sensitization of naive 2W:I-Ab Tconvs.

Options: View larger image (or click on image) Download as PowerPoint
Presensitization to donor Cre antigen results in linked sensitization of...
(A) Experimental design. B6 female mice were sensitized to Cre.B6 or 2W-OVA skin grafts, and after 60–90 days, were transplanted with Cre+2W-OVA.F1 hearts and received anti-CD154/DST (Cre-S-Tol and 2W-OVA-S-Tol, respectively). Naïve mice receiving Cre+2W-OVA.F1 hearts were included as controls (N-Tol). (B) Number of 2W:I-Ab CD4+ T cells recovered from spleen + lymph nodes per mouse before heart transplant (POD 0) and percentage of 2W:I-Ab CD4+ T cells expressing CD44. (n = 3–7 mice per group.) (C) Heart graft survival on POD 30 and POD 60. (D) Heart graft palpation score in N-Tol, 2W-OVA-S-Tol, and Cre-S-Tol recipients through POD 60. (E) Number of 2W:I-Ab Tconvs, (F) Tregs, and (G) percentage Tregs of 2W:I-Ab CD4+ T cells recovered from spleen + lymph nodes per mouse on POD 45–60. Each symbol represents a single mouse, and each experiment was repeated 2–3 times (n = 3–7 mice per group). Data are presented as mean ± STDEV, and statistical significance was assessed by 1-way ANOVA and Tukey’s or repeated measures ANOVA. *P < 0.05; **P < 0.005; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts